Prelude Capital Management’s Abiomed Inc ABMD Stock Holding History
Bought
Maintained
Sold
Other funds holding ABMD
TRSOTSOK
BTI
IA
AW
HNB
Prelude Capital Management's ABMD Position: Q4 2022 in Review
Prelude Capital Management sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 1,013 shares — an estimated $249K sold.
Prelude Capital Management first reported a position in ABMD in Q4 2013 and held it in 19 quarters. The position peaked at $704K in Q2 2022. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.
- Prelude Capital Management reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
- Prelude Capital Management sold 1,013 Abiomed Inc shares in Q4 2022, an estimated $249K.
- Prelude Capital Management first reported a position in Abiomed Inc in Q4 2013 and held it in 19 quarters.
- Prelude Capital Management's Abiomed Inc position peaked at $704K in Q2 2022.
- 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.
Based on Prelude Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.